openPR Logo
Press release

The Value of Canine Flu Therapeutics Market Estimated to Soar Higher During 2017-2027

12-01-2017 07:12 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
The Value of Canine Flu Therapeutics Market Estimated to Soar

Canine flu (also known as dog flu) is a contagious respiratory disease in dogs mainly caused by Type A influenza/canine influenza virus. They are two various kinds of influenza viruses namely H3N8 virus and H3N2. Canine flu originated in horses, spread to dogs, and now spreads in between dogs only. The symptoms of illness are upper respiratory illness, eye discharges, reduced appetite, cough, runny nose, fever, and lethargy, but not all dogs show signs of flu. The severity of canine flu ranges from no symptoms to terminal illness resulting in pneumonia and sometimes death. Most dogs recover from canine flu within 2 to 3 weeks, but some dogs develop a secondary infection which may lead to death. Canine flu is mostly airborne through nasal secretions. To reduce the spread of flu, mostly dogs isolated that are showing symptoms. Canine flu diagnosed by physical examination, blood test (Neutrophils count increases), a bronchoscope (It is used characterize the type of pneumonia). The treatment for canine flu mainly depends on health condition, and medication especially includes supportive treatment, antibiotics, and anti-inflammatory drugs. Vaccination is used to prevent the canine flu and considered as lifestyle vaccines (It means the vaccination mainly depends on the risk of exposure).

Canine Flu Therapeutics Market: Drivers and Restraints

Almost all dogs are susceptible to canine flu with direct contact with respiratory discharges from infected dogs. According to the study of the University of Wisconsin, the H3N2 virus may retain for a longer period than an H3N8 virus. It results in the spread of canine flu among others dogs with multiple outbreaks. The occurrence of H3N2 virus or H3N8 virus is unpredictable, and so dogs need to be protected from the canine flu. Because dogs cannot maintain immunity against the canine influenza virus. There is no specific treatment for canine flu which acts as a driver for discovering the new drugs. There is a high unmet need for treating of canine flu, which gives the great potential market for new drugs. All these factors act as drivers in the burgeoning growth of canine flu therapeutic market.

Read Report Overview@ https://www.futuremarketinsights.com/reports/canine-flu-therapeutics-market

Canine flu is non-symptomatic till the terminal stage of illness. It results in either death of the dogs or development of secondary infection like pneumonia which makes it difficult to treat. All these factors act as restraints in the growth of the canine flu therapeutics market.

Canine Flu Therapeutics Market: Segmentation

Segmentation based on Therapeutics Market

Vaccines

Antibiotics

Anti-Inflammatory drugs

Others

Segmentation based on End User

Veterinary Hospitals

Vet Clinics

Animal Healthcare Facilities

Canine Flu Therapeutics Market: Market Overview

Global Canine Flu Therapeutics Market has witnessed a robust growth due to increasing incidence of disease and with no specific treatment. Because of no specific treatment for the canine flu, innovators can get an advantage of the monopolistic market with less competition across the globe. The government is also supporting canine flu therapeutics manufacturers to develop therapeutics for the flu to control outbreaks. Which drive companies to focus towards innovation in canine flu therapeutics market. A new trend is observed in manufactures, that they are mainly focusing on prevention rather than cure. It gives new opportunities to innovators for developing new medicine for canine flu. The future expected with double CAGR during forecasted period.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4315

Canine Flu Therapeutics Market: Region-Wise Overview

Global Canine Flu Therapeutics Market segmented into following regions North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and the Middle East and Africa. North Americais dominant in the Global canine flu therapeutic market mainly due to the high penetration. In North America, particularly the USA is dominating due to the high adoption of treatment method to the canine flu. Economic conditions in the APAC region are set to drive the Canine Flu Therapeutics Market to new heights. European and APAC are fastest growing region due to increasing awareness of flu. Growth in the Middle East and African region is considerably less when compared to other parts of the globe.

Canine Flu Therapeutics Market: Key Participants

The key participants of global canine flu therapeutics market are Intervet Inc., a subsidiary of Merck & Co, Zoetis Services LLC. The company is mainly focusing on mergers and acquisition to develop innovative drugs.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Value of Canine Flu Therapeutics Market Estimated to Soar Higher During 2017-2027 here

News-ID: 840478 • Views:

More Releases from Future Market Insights

Electronic Tongue Market will grow USD 774.2 million by 2035, at a 4.5% CAGR, fueled by demand for smart diagnostics and medical R&D.
Electronic Tongue Market will grow USD 774.2 million by 2035, at a 4.5% CAGR, fu …
The global electronic tongue market is advancing rapidly, poised to reach USD 497.9 million in 2025 and climb to USD 774.2 million by 2035, growing at a promising 4.5% CAGR. The increasing demand for precision diagnostics, pharmaceutical quality control, and personalized medicine is driving this technological surge, positioning the electronic tongue as a futuristic, non-invasive diagnostic instrument in healthcare and pharmaceuticals. Electronic tongues, by design, mimic human sensory functions through an
ESD Tapes and Labels market will expand USD 4,253.3 million by 2035, growing at 4.5% CAGR with strong electronics and aerospace demand.
ESD Tapes and Labels market will expand USD 4,253.3 million by 2035, growing at …
The global market for ESD (electrostatic discharge) tapes and labels is entering a new decade of expansion driven by technological innovation, the rise of miniaturized electronics, and heightened quality standards in manufacturing. Valued at USD 2,738.8 million in 2025, the market is expected to reach USD 4,253.3 million by 2035, expanding at a steady 4.5% CAGR. This reflects a world increasingly dependent on efficient anti-static solutions that ensure the protection
Catalase Market will rise USD 575.9 million by 2035 at 3.1% CAGR, driven by sustainable innovations and expanding applications.
Catalase Market will rise USD 575.9 million by 2035 at 3.1% CAGR, driven by sust …
The global market for catalase is preparing for steady long-term expansion, driven by green chemistry, renewable sourcing, and biotechnology-driven production upgrades. Projected to reach USD 424.5 million in 2025 and USD 575.9 million by 2035, the industry's 3.1% CAGR reflects its broadening influence across critical sectors including food and beverages, pharmaceuticals, textiles, and personal care. With growing concerns about sustainability, efficiency, and safety, catalase is emerging as a vital biocatalyst
Quillaia Extract market is set to reach USD 1,826.9M by 2035 at 5.8% CAGR fueled by natural, functional, and sustainable trends.
Quillaia Extract market is set to reach USD 1,826.9M by 2035 at 5.8% CAGR fueled …
The global Quillaia extract market is entering a period of unprecedented growth, reflecting the world's shift toward natural, functional, and nutrient-rich ingredients. Projected to increase from USD 1,039.6 million in 2025 to USD 1,826.9 million by 2035 at a robust 5.8% CAGR, the industry's future is shaped by consumer demand for healthier, eco-friendly products and manufacturers' determination to stay ahead through innovation, expansion, and diversification. Over the past few years, Quillaia

All 5 Releases


More Releases for Canine

Alternative Canine Training Shares Expert Tips to Help Metro Detroit Families Ad …
LIVONIA, MI - August 8, 2025 Alternative Canine Training, Metro Detroit's trusted leader in dog behavior and obedience training, has released a new blog post designed to help dog owners safely and effectively socialize aggressive dogs. The article, "Socialize an Aggressive Dog: Strategies for Successful Integration," provides actionable advice for families navigating the emotional and logistical challenges posed by canine aggression. Drawing on over 20 years of hands-on experience in behavior
Major Growth Driver Identified in 2025 Canine Arthritis Treatment Market: Rising …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Canine Arthritis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the market size of canine arthritis treatment has significantly expanded. The projections show it will increase from $2.35 billion in 2024 to $2.48 billion in 2025, with a compound
Major Market Shift in Canine Arthritis Treatment Industry: Innovative Solutions …
What Is the Forecasted Market Size and Growth Rate for the Canine Arthritis Treatment Market? The market for treating canine arthritis has seen significant expansion recently. An increase from $2.35 billion in 2024 to $2.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.6%, is projected. Factors contributing to this growth during the historic period include a rise in the age of the pet population, heightened awareness among
Canine Weight Set Registered Introduces Revolutionary Products for Enhanced Cani …
Innovative Solutions Set to Transform Dog Training and Health CANINE WEIGHT SET Registered [https://www.canineweightset.com/], a leader in canine fitness solutions, has launched a new range of high-quality weighted vests and harnesses designed to improve the strength, agility, and overall well-being of service dogs and pets. This announcement marks a significant step forward in dog training and health, offering products that prioritize both physical and mental wellness. FOR ALL DOG BREEDS Image: https://www.abnewswire.com/uploads/5a2a46243440cfce2a61f418b4b969b9.jpg A Passion
Canine Arthritis Treatment Market Size 2024 to 2031.
Market Overview and Report Coverage Canine Arthritis Treatment Market refers to the market for products and therapies specifically designed to alleviate arthritis symptoms in dogs. Arthritis is a common condition in aging dogs, causing pain, stiffness, and decreased mobility. The market offers a range of options, including medications, supplements, physical therapy, and surgical interventions. The current outlook of the Canine Arthritis Treatment Market is positive, with steady growth projected in
02-19-2024 | Health & Medicine
Stryde
Stryde Fish Oil For Optimal Canine Nutrition
The popularity of canine supplements has surged in recent years, offering a range of nutritional benefits to enhance your pet's overall well-being. Available in diverse varieties, these supplements cater to various aspects of your pet's health. Each supplement is formulated to target specific health concerns like flaky skin and joint pain, but fish oil supplements have emerged as the most popular choice among pet owners. Fish oil contains omega-3 fatty acids like